Impact of Combined “CHADS-BLED” Score to Predict Short-Term Outcomes in Transfemoral and Transapical Aortic Valve Replacement

Figure 2

Kaplan–Meier survival curves for 30-day mortality and adverse event rates according to high and low combined CHADS-BLED score in patients with AF. (a) Kaplan–Meier survival curves according to the combined CHADS-BLED score in TF TAVR patients with AF. (b) Awarding of adverse event rates according to high and low combined CHADS-BLED score in TF TAVR patients with AF.

(a)

(b)